Pricing
  1. US-listed companies
  2. EAGLE PHARMACEUTICALS, INC.
  3. Financials
  4. Cash from investing

EAGLE PHARMACEUTICALS, INC.【EGRX】

Market cap
$14.29K
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2022-87+1531.22%
Dec 31, 2021-5-70.83%
Dec 31, 2020-18+2248.39%
Dec 31, 2019-1+484.21%
Dec 31, 2018-0-97.44%
Dec 31, 2017-5-88.68%
Dec 31, 2016-46+2334.88%
Dec 31, 2015-2-90.62%
Sep 30, 2014-20

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)